Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Celldex Therapeutics, Inc. | SVP & GENERAL COUNSEL | Common Stock | 35.5K | $368K | $10.38 | Jun 5, 2024 | Direct |
Celldex Therapeutics, Inc. | SVP & GENERAL COUNSEL | Incentive Stock Option (right to buy) | 75K | Jun 13, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CLDX | Celldex Therapeutics, Inc. | Jun 13, 2024 | 1 | $0 | 4 | Jun 17, 2024 | SVP & GENERAL COUNSEL |
CLDX | Celldex Therapeutics, Inc. | Jun 5, 2024 | 2 | $99K | 4 | Jun 7, 2024 | SVP & GENERAL COUNSEL |
CLDX | Celldex Therapeutics, Inc. | Jun 3, 2024 | 3 | -$186K | 4 | Jun 5, 2024 | SVP & GENERAL COUNSEL |
CLDX | Celldex Therapeutics, Inc. | Feb 13, 2024 | 4 | $93.2K | 4 | Feb 15, 2024 | SVP & GENERAL COUNSEL |
CLDX | Celldex Therapeutics, Inc. | Jun 15, 2023 | 1 | $0 | 4 | Jun 20, 2023 | SVP & GENERAL COUNSEL |
CLDX | Celldex Therapeutics, Inc. | Jun 16, 2022 | 1 | $0 | 4 | Jun 17, 2022 | SVP & GENERAL COUNSEL |
CLDX | Celldex Therapeutics, Inc. | Aug 11, 2021 | 1 | $19.9K | 4 | Aug 13, 2021 | SVP & General Counsel |
CLDX | Celldex Therapeutics, Inc. | Jun 17, 2021 | 1 | $0 | 4 | Jun 21, 2021 | SVP & General Counsel |